Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

IsoFlow

IsoFlow
2001 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of a drug infusion system for the people suffering from cancer. The company develops and markets an endovascular device which provides direct drug delivery to tumors and other delivery applications.

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Therapeutic Devices
Primary Office
  • 4960 Almaden Expressway
  • San Jose, CA 95118
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore IsoFlow’s full profile, request a free trial.

IsoFlow Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-May-2016 00.000 Completed Out of Business
2. Angel (individual) 17-Dec-2010 00000 00.000 Completed Generating Revenue
1. Angel (individual) 11-Jan-2008 $1.68M $1.68M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

IsoFlow Executive Team (1)

Name Title Board
Seat
Contact
Info
Robert Goldman Co-Founder, President, Chief Technology Officer, Chief Executive Officer & Chairman

IsoFlow Board Members (2)

Name Representing Role Since Contact
Info
Joe Maemone IsoFlow Board Member 000 0000
Robert Goldman Self Co-Founder, President, Chief Technology Officer, Chief Executive Officer & Chairman 000 0000